Privia Health Group (NASDAQ:PRVA) Given “Market Outperform” Rating at JMP Securities

JMP Securities reiterated their market outperform rating on shares of Privia Health Group (NASDAQ:PRVA) in a report released on Friday morning,Benzinga reports. The brokerage currently has a $26.00 target price on the stock.

Other analysts have also issued research reports about the company. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Truist Financial raised their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Barclays raised their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Stephens reaffirmed an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Finally, Macquarie assumed coverage on Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. Two analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group currently has an average rating of “Buy” and an average price target of $24.94.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $25.24 on Friday. The firm has a market cap of $3.03 billion, a PE ratio of 252.43, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $25.49. The business has a 50 day moving average price of $21.62 and a 200-day moving average price of $20.23.

Hedge Funds Weigh In On Privia Health Group

Institutional investors and hedge funds have recently modified their holdings of the stock. Nordea Investment Management AB increased its holdings in shares of Privia Health Group by 33.1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after acquiring an additional 86,910 shares in the last quarter. Victory Capital Management Inc. increased its holdings in Privia Health Group by 402.9% in the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after buying an additional 143,446 shares in the last quarter. Franklin Resources Inc. increased its holdings in Privia Health Group by 2.2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after buying an additional 28,480 shares in the last quarter. Barclays PLC increased its holdings in Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after buying an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Privia Health Group by 8.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after buying an additional 14,641 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.